Less than one-third of people with hepatitis C get timely treatment
New data from a CDC Vital Signs report show that less than one-third of people with hepatitis C receive treatment within 1 year of their diagnosis despite the availability of direct-acting antivirals.“Roughly 1% of the U.S. adult population has hepatitis C. It is a leading cause of death in the U.S., contributing to the deaths of about 14,000 people each year,” CDC Acting Principal Deputy Director Debra E. Houry, MD, MPH, said during a press briefing.Houry said the number of new HCV infections in the U.S. has steadily increased since 2010, which she said is “another direRead More
